Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived components.

The influence of endotoxin-induced elevated plasma levels of the fast-acting inhibitor of plasminogen activator (PA-inhibitor) on thrombolysis was investigated in rabbits with a jugular vein thrombus. Infusion of human tissue-type plasminogen activator (t-PA) produced similar degrees of thrombolysis in control and endotoxin-treated rabbits, although no free t-PA could be demonstrated in plasma of endotoxin-treated animals. Infusion of t-PA in an extracorporeal arteriovenous shunt resulted in loss of thrombolytic activity in endotoxin-treated animals but not in control animals. Blood clots superfused in vitro with mixtures of t-PA and normal plasma lysed in contrast to clots superfused with t-PA and PA-inhibitor-rich plasma. However, addition of rabbit lung slices to the plasma surrounding the blood clot, reversed the inhibition of thrombolysis by PA-inhibitor-rich plasma. This indicates that tissue-derived factor(s) are involved in the regulation of in vivo thrombolysis. These hypothetical factor(s) are, however, very unstable in plasma, which has thus far precluded their further characterization.

[1]  J. Paramo,et al.  Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. , 1985, The Journal of clinical investigation.

[2]  P. Gaffney,et al.  A Collaborative Study of a Proposed International Standard for Tissue Plasminogen Activator (t-PA) , 1985, Thrombosis and Haemostasis.

[3]  S. Thorsen,et al.  Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma. Evidence for a rapid plasminogen activator inhibitor. , 1984, Biochimica et biophysica acta.

[4]  B. Wiman,et al.  The Fast Inhibitor of Tissue Plasminogen Activator in Plasma During Pregnancy , 1984, Thrombosis and Haemostasis.

[5]  E. Kruithof,et al.  Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. , 1984, Blood.

[6]  D. Collen,et al.  Influence of exogenous and endogenous tissue-type plasminogen activator on the lysability of clots in a plasma milieu in vitro. , 1984, Thrombosis research.

[7]  J. Verheijen,et al.  Evidence for the Occurrence of a Fast-Acting Inhibitor for Tissue-Type Plasminogen Activator in Human Plasma , 1984, Thrombosis and Haemostasis.

[8]  D. Collen,et al.  Inhibition of trypsin-like serine proteinases by tripeptide arginyl and lysyl chloromethylketones. , 1984, Thrombosis Research.

[9]  D. Collen,et al.  Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions. , 1984, Thrombosis research.

[10]  E. Levin.  Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[11]  B. Wiman,et al.  Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. , 1983, Thrombosis research.

[12]  D. Lawrence,et al.  Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Collen,et al.  Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assay. , 1983, The Journal of laboratory and clinical medicine.

[14]  M. Verstraete,et al.  Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration. , 1983, The Journal of clinical investigation.

[15]  V. V. van Hinsbergh,et al.  Inhibition of tissue-type plasminogen activator by conditioned medium from cultured human and porcine vascular endothelial cells. , 1983, Biochemical and biophysical research communications.

[16]  E. Mullaart,et al.  A Simple, Sensitive Spectrophotometric Assay for Extrinsic (Tissue-Type) Plasminogen Activator Applicable to Measurements in Plasma , 1982, Thrombosis and Haemostasis.

[17]  C. Korninger,et al.  Studies on the Specific Fibrinolytic Effect of Human Extrinsic (Tissue-Type) Plasminogen Activator in Human Blood and in Various Animal Species in Vitro , 1981, Thrombosis and Haemostasis.

[18]  D. Collen,et al.  Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. , 1981, The Journal of biological chemistry.

[19]  D. Collen.  On the Regulation and Control of Fibrinolysis , 1980, Thrombosis and Haemostasis.

[20]  D. Collen,et al.  Inhibition of plasmin by normal and antiplasmin-depleted human plasma. , 1976, Thrombosis research.

[21]  D. Deutsch,et al.  Plasminogen: Purification from Human Plasma by Affinity Chromatography , 1970, Science.

[22]  M. Verstraete,et al.  A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT test). , 1963, Clinica chimica acta; international journal of clinical chemistry.

[23]  T. Astrup,et al.  The fibrin plate method for estimating fibrinolytic activity. , 1952, Archives of biochemistry and biophysics.

[24]  P. Fraker,et al.  PROTEIN AND CELL MEMBRANE IODINATION WITH A SPARINGLY SOLUBLE CHLOROAMIDE , 1978 .